Brief: MyMD Pharmaceuticals Enrolls First Patient In Phase 2 Clinical Trial Of MYMD-1 As Therapy For Delaying Aging And Extending Healthy Lifespan
23/02/2022 14:18
Feb 23 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS ENROLLS FIRST PATIENT IN PHASE 2
CLINICAL
TRIAL OF MYMD-1 AS A THERAPY FOR DELAYING AGING AND EXTENDING
HEALTHY LIFESPAN
* MYMD PHARMACEUTICALS INC - EFFICACY DATA FROM FULLY FUNDED
PHASE
2 TRIAL IS EXPECTED IN FIRST HALF OF 2022
Source text for Eikon: ID:nBwLbmSza
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))